Health Care Archives - Page 397 of 478

1 minute read

Eiger BioPharma Shuns Plans For FDA Emergency Use Nod For COVID-19 Treatment

October 5, 9:50 AM

Following FDA feedback, Eiger BioPharmaceuticals Inc (NASDAQ:EIGR) will not submit an emergency use authorization (EUA) application of peginterferon lambda for mild-to-moderate COVID-19.…

EIGR

1 minute read

Sight Sciences’ Near-Term Upside Is Limited, Says This Analyst

By Vandana Singh

October 4, 3:38 PM

Needham initiated coverage on Sight Sciences Inc (NASDAQ:SGHT) with a Hold rating and no price target. The analyst warns that the recent competitive…

SGHT

1 minute read

Needham Says Recent Launches To Drive Market Share Recovery For This Eye-Focused MedTech Stock

By Vandana Singh

October 4, 2:27 PM

Needham initiated coverage on Glaukos Corp (NYSE:GKOS) with a price target of $66 and a Buy rating. The analyst writes that GKOS has…

GKOS

1 minute read

Despite Solid Efficacy From Gene Therapy, This Analyst Cuts REGENXBIO’s Price Target

By Vandana Singh

October 4, 2:18 PM

On Monday, REGENXBIO Inc (NASDAQ:RGNX) announced a program update from its ongoing clinical investigation of RGX-314 for wet AMD, a leading cause…

RGNX

1 minute read

Sanofi In-Licenses Preclinical Genetic Disease Candidate From An Unknown Biotech

By Vandana Singh

October 4, 1:18 PM

French pharma major Sanofi SA (NASDAQ:SNY) entered into a collaboration and licensing agreement with little-known U.S. biotech miRecule, an innovator of next-generation…

SNY

1 minute read

Vir Biotech Secures US Government Contract For Influenza & Other Infectious Disease Candidates

By Vandana Singh

October 4, 12:56 PM

With its COVID-19 monoclonal antibody sidelined in the U.S. since April and plans for full approval no longer in the cards, Vir…

VIR

1 minute read

Summit Therapeutics Seeks Partnership For Phase 3 Infection Candidate Development

By Vandana Singh

October 4, 11:49 AM

In an SEC filing, Summit Therapeutics Inc (NASDAQ: SMMT) said it would seek partners or divestiture of ridinilazole as the path forward for the clinical development of the asset.

SMMT

1 minute read

Connect Biopharma Lead Candidate Aces Pivotal Atopic Dermatitis Trial In Chinese Patients

By Vandana Singh

October 4, 11:40 AM

Connect Biopharma Holdings Limited (NASDAQ:CNTB) announced topline results for the primary analysis population of the pivotal trial of CBP-201, in patients…

CNTB

1 minute read

FDA Puts Partial Hold On Aeglea’s Rare Disorder Trial In Pediatric Patients

By Vandana Singh

October 4, 11:05 AM

Aeglea BioTherapeutics Inc (NASDAQ:AGLE) received an FDA letter responding to a recently submitted protocol amendment for the Phase 1/2 trial of…

AGLE

1 minute read

Pfizer Touts Positive Data From Prostate Cancer Combo Therapy Trial

By Vandana Singh

October 4, 10:54 AM

Pfizer Inc (NYSE:PFE) announced topline results from the Phase 3 TALAPRO-2 study of Talzenna (talazoparib) in combination with Xtandi (enzalutamide) in…

PFE